Get the Stockscreener App
1.38
1.47%
0.02
Pre-market:
1.38
Matinas Biopharma Holdings Inc stock is traded at $1.38, with a volume of 24,813.
It is up +1.47% in the last 24 hours and down -26.98% over the past month.
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. The company enables the delivery of life-changing medicines using its lipid nano-crystal (LNC) platform technology. Its LNC delivery technology platform utilizes lipid nano-crystals which can encapsulate small molecules, oligonucleotides, vaccines, peptides, proteins and other medicines potentially making them safer, more tolerable, less toxic, and orally bioavailable. The company's lead anti-fungal product candidate is MAT2203, an orally-administered cochleate formulation of amphotericin B that has completed Phase II clinical trials for the prevention of invasive fungal infections due to immunosuppressive therapy in patients with acute lymphoblastic leukemia. Its product candidates also comprise MAT2501, an orally administered cochleate formulation of the broad spectrum aminoglycoside antibiotic amikacin that has completed Phase I clinical trials to treat various types of multidrug-resistant bacteria, including non-tuberculous mycobacterium infections, as well as various multidrug-resistant gram negative and intracellular bacterial infections. The company was founded in 2013 and is based in Bedminster, New Jersey.
See More
Previous Close:
$1.36
Open:
$1.36
24h Volume:
24,813
Relative Volume:
0.05
Market Cap:
$7.02M
Revenue:
-
Net Income/Loss:
$-21.13M
P/E Ratio:
-0.2881
EPS:
-4.79
Net Cash Flow:
$-16.95M
1W Performance:
-13.75%
1M Performance:
-26.98%
6M Performance:
+133.50%
1Y Performance:
+122.58%
1-Day Range:
$1.3404
$1.42
1-Week Range:
$1.332
$1.67
52-Week Range:
$0.4748
$3.09
Matinas Biopharma Holdings Inc Stock (MTNB) Company Profile
Name
Matinas Biopharma Holdings Inc
Sector
Industry
Phone
908-443-1860
Address
1545 Route 206 South, Suite 302, Bedminster, NJ
Compare MTNB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MTNB
Matinas Biopharma Holdings Inc
|
1.38 | 7.55M | 0 | -21.13M | -16.95M | -4.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Matinas Biopharma Holdings Inc Stock (MTNB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-11-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-26-20 | Resumed | Piper Sandler | Overweight |
| Jan-27-20 | Initiated | Piper Sandler | Overweight |
| Jan-24-20 | Initiated | SunTrust | Buy |
| Jan-23-20 | Initiated | SunTrust | Buy |
| Jan-09-20 | Initiated | Aegis Capital | Buy |
| Jun-26-19 | Initiated | H.C. Wainwright | Buy |
View All
Matinas Biopharma Holdings Inc Stock (MTNB) Latest News
Can Matinas BioPharma Holdings Inc. stock maintain operating marginsJuly 2025 Technicals & Real-Time Volume Analysis Alerts - newser.com
How Matinas BioPharma Holdings Inc. stock compares to market leadersPortfolio Return Summary & Expert Approved Momentum Trade Ideas - newser.com
Technical analysis overview for Matinas BioPharma Holdings Inc. stock2025 Trading Recap & Fast Exit and Entry Strategy Plans - newser.com
Is Matinas BioPharma Holdings Inc. stock bottoming outPortfolio Risk Report & Reliable Price Action Trade Plans - newser.com
How moving averages guide Matinas BioPharma Holdings Inc. tradingEarnings Recap Summary & Precise Trade Entry Recommendations - newser.com
Will Matinas BioPharma Holdings Inc. (6LJ0) stock outperform value peersDollar Strength & Safe Investment Capital Preservation Plans - newser.com
What dividend safety rating applies to Matinas BioPharma Holdings Inc. (6LJ0) stockJuly 2025 Market Mood & High Accuracy Trade Signal Alerts - newser.com
Matinas BioPharma Holdings Inc 6LJ0 Stock Analysis and ForecastMarket Breadth Indicators & High-Risk, High-Reward? We Find the Winners - earlytimes.in
Sector ETF performance correlation with Matinas BioPharma Holdings Inc.Earnings Risk Summary & Fast Entry High Yield Tips - newser.com
Is Matinas Biopharma Holdings Inc. stock prepared for digital transition2025 Biggest Moves & AI Powered Buy and Sell Recommendations - newser.com
How Matinas BioPharma Holdings Inc. (6LJ0) stock reacts to new regulationsMarket Movers & Fast Entry High Yield Tips - newser.com
Will Matinas BioPharma Holdings Inc. stock attract ESG investorsSell Signal & Long-Term Safe Investment Ideas - newser.com
Is Matinas Biopharma Holdings Inc. stock supported by free cash flowRate Cut & Weekly Chart Analysis and Trade Guides - newser.com
Can Matinas Biopharma Holdings Inc. stock sustain revenue momentumJuly 2025 Short Interest & Weekly Breakout Watchlists - newser.com
Can Matinas Biopharma Holdings Inc. stock resist broad market declinesMarket Movement Recap & Daily Profit Focused Stock Screening - newser.com
What technical charts say about Matinas BioPharma Holdings Inc. stockAnalyst Downgrade & Long-Term Safe Investment Plans - newser.com
Detecting support and resistance levels for Matinas BioPharma Holdings Inc.July 2025 Selloffs & Risk Managed Investment Strategies - newser.com
Key metrics from Matinas BioPharma Holdings Inc.’s quarterly dataMarket Rally & Weekly Breakout Opportunity Watchlist - newser.com
What makes Simon Property Group, Inc. stock price move sharply - newser.com
What makes Matinas Biopharma Holdings Inc. stock appealing to growth investorsAnalyst Downgrade & High Conviction Buy Zone Alerts - newser.com
Will Matinas Biopharma Holdings Inc. stock test record highs in 2025Weekly Profit Report & Community Trade Idea Sharing - newser.com
Total debt per share of Matinas BioPharma Holdings, Inc. – MUN:6LJ0 - TradingView
Matinas Biopharma Holdings Inc Stock (MTNB) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):